LAG3 and COVID-19: We also found that sCTLA-4 and sLAG-3, 2 sICPs that were studied by Kong and Avendano-Ortiz et al. with conflicting results, were elevated in plasma from patients with severe/critical COVID-19 when compared with healthy controls (Figure 1B), which is in agreement with Kong’s results.